Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
03 2023
Historique:
received: 23 03 2022
accepted: 13 01 2023
pubmed: 17 2 2023
medline: 4 3 2023
entrez: 16 2 2023
Statut: ppublish

Résumé

Blocking pyrimidine de novo synthesis by inhibiting dihydroorotate dehydrogenase is used to treat autoimmunity and prevent expansion of rapidly dividing cell populations including activated T cells. Here we show memory T cell precursors are resistant to pyrimidine starvation. Although the treatment effectively blocked effector T cells, the number, function and transcriptional profile of memory T cells and their precursors were unaffected. This effect occurred in a narrow time window in the early T cell expansion phase when developing effector, but not memory precursor, T cells are vulnerable to pyrimidine starvation. This vulnerability stems from a higher proliferative rate of early effector T cells as well as lower pyrimidine synthesis capacity when compared with memory precursors. This differential sensitivity is a drug-targetable checkpoint that efficiently diminishes effector T cells without affecting the memory compartment. This cell fate checkpoint might therefore lead to new methods to safely manipulate effector T cell responses.

Identifiants

pubmed: 36797499
doi: 10.1038/s41590-023-01436-x
pii: 10.1038/s41590-023-01436-x
doi:

Substances chimiques

Pyrimidines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

501-515

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177–187 (1998).
pubmed: 9491999 doi: 10.1016/S1074-7613(00)80470-7
Best, J. A. et al. Transcriptional insights into the CD8
pubmed: 23396170 pmcid: 3689652 doi: 10.1038/ni.2536
Lugli, E., Galletti, G., Boi, S. K. & Youngblood, B. A. Stem, effector and hybrid states of memory CD8
pubmed: 31810790 doi: 10.1016/j.it.2019.11.004
Pace, L. et al. The epigenetic control of stemness in CD8
pubmed: 29326266 doi: 10.1126/science.aah6499
Geltink, R. I. K., Kyle, R. L. & Pearce, E. L. Unraveling the complex interplay between T cell metabolism and function. Annu Rev. Immunol. 36, 461–488 (2018).
pubmed: 29677474 doi: 10.1146/annurev-immunol-042617-053019
Buchholz, V. R. et al. Disparate individual fates compose robust CD8
pubmed: 23493420 doi: 10.1126/science.1235454
Herndler-Brandstetter, D. et al. KLRG1
pubmed: 29625895 pmcid: 6465538 doi: 10.1016/j.immuni.2018.03.015
Jameson, S. C. & Masopust, D. Understanding subset diversity in T cell memory. Immunity 48, 214–226 (2018).
pubmed: 29466754 pmcid: 5863745 doi: 10.1016/j.immuni.2018.02.010
Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708–712 (1999).
pubmed: 10537110 doi: 10.1038/44385
Thome, J. J. et al. Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell 159, 814–828 (2014).
pubmed: 25417158 pmcid: 4243051 doi: 10.1016/j.cell.2014.10.026
Urban, S. L. et al. Peripherally induced brain tissue-resident memory CD8
pubmed: 32572242 pmcid: 7381383 doi: 10.1038/s41590-020-0711-8
Arens, R. & Schoenberger, S. P. Plasticity in programming of effector and memory CD8 T cell formation. Immunol. Rev. 235, 190–205 (2010).
pubmed: 20536564 pmcid: 2937176 doi: 10.1111/j.0105-2896.2010.00899.x
Gattinoni, L. et al. Wnt signaling arrests effector T cell differentiation and generates CD8
pubmed: 19525962 pmcid: 2707501 doi: 10.1038/nm.1982
Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8
pubmed: 17723218 pmcid: 2034442 doi: 10.1016/j.immuni.2007.07.010
Kaech, S. M. et al. Selective expression of the interleukin-7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4, 1191–1198 (2003).
pubmed: 14625547 doi: 10.1038/ni1009
Martin, M. D. & Badovinac, V. P. Defining memory CD8 T cell. Front Immunol. 9, 2692 (2018).
pubmed: 30515169 pmcid: 6255921 doi: 10.3389/fimmu.2018.02692
Hess Michelini, R., Doedens, A. L., Goldrath, A. W. & Hedrick, S. M. Differentiation of CD8 memory T cells depends on Foxo1. J. Exp. Med. 210, 1189–1200 (2013).
pubmed: 23712431 doi: 10.1084/jem.20130392
Jeannet, G. et al. Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc. Natl Acad. Sci. USA 107, 9777–9782 (2010).
pubmed: 20457902 pmcid: 2906901 doi: 10.1073/pnas.0914127107
Kim, M. V., Ouyang, W., Liao, W., Zhang, M. Q. & Li, M. O. The transcription factor Foxo1 controls central-memory CD8
pubmed: 23932570 doi: 10.1016/j.immuni.2013.07.013
Milner, J. J. et al. Heterogenous populations of tissue-resident CD8
pubmed: 32433949 pmcid: 7784612 doi: 10.1016/j.immuni.2020.04.007
Zhao, D. M. et al. Constitutive activation of Wnt signaling favors generation of memory CD8 T cells. J. Immunol. 184, 1191–1199 (2010).
pubmed: 20026746 doi: 10.4049/jimmunol.0901199
Zhou, X. et al. Differentiation and persistence of memory CD8
pubmed: 20727791 pmcid: 2928475 doi: 10.1016/j.immuni.2010.08.002
Raczkowski, F. et al. The transcription factor Interferon regulatory factor 4 is required for the generation of protective effector CD8
pubmed: 23980171 pmcid: 3773801 doi: 10.1073/pnas.1309378110
Starbeck-Miller, G. R., Xue, H. H. & Harty, J. T. IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo. J. Exp. Med. 211, 105–120 (2014).
pubmed: 24367005 pmcid: 3892973 doi: 10.1084/jem.20130901
Sullivan, B. M., Juedes, A., Szabo, S. J., von Herrath, M. & Glimcher, L. H. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl Acad. Sci. USA 100, 15818–15823 (2003).
pubmed: 14673093 pmcid: 307651 doi: 10.1073/pnas.2636938100
Xue, L., Chiang, L., He, B., Zhao, Y. Y. & Winoto, A. FoxM1, a forkhead transcription factor is a master cell cycle regulator for mouse mature T cells but not double positive thymocytes. PLoS ONE 5, e9229 (2010).
pubmed: 20169079 pmcid: 2821927 doi: 10.1371/journal.pone.0009229
Yang, C. Y. et al. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8
pubmed: 22057289 doi: 10.1038/ni.2158
Broen, J. C. A. & van Laar, J. M. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology. Nat. Rev. Rheumatol. 16, 167–178 (2020).
pubmed: 32055040 doi: 10.1038/s41584-020-0374-8
Aly, L., Hemmer, B. & Korn, T. From leflunomide to teriflunomide: drug development and immunosuppressive oral drugs in the treatment of multiple sclerosis. Curr. Neuropharmacol. 15, 874–891 (2017).
pubmed: 27928949 pmcid: 5652031 doi: 10.2174/1570159X14666161208151525
Thoenes, G. H., Sitter, T., Langer, K. H., Bartlett, R. R. & Schleyerbach, R. Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats. Int. J. Immunopharmacol. 11, 921–929 (1989).
pubmed: 2613396 doi: 10.1016/0192-0561(89)90114-8
Herrmann, M. L., Schleyerbach, R. & Kirschbaum, B. J. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases. Immunopharmacology 47, 273–289 (2000).
pubmed: 10878294 doi: 10.1016/S0162-3109(00)00191-0
Cherwinski, H. M. et al. The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis. J. Pharmacol. Exp. Ther. 275, 1043–1049 (1995).
pubmed: 7473131
Chong, A. S. et al. Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation. Transplantation 55, 1361–1366 (1993).
pubmed: 8390735 doi: 10.1097/00007890-199306000-00028
Zehn, D., Lee, S. Y. & Bevan, M. J. Complete but curtailed T cell response to very low-affinity antigen. Nature 458, 211–214 (2009).
pubmed: 19182777 pmcid: 2735344 doi: 10.1038/nature07657
Chan, V., Charles, B. G. & Tett, S. E. Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis. Br. J. Clin. Pharm. 60, 257–264 (2005).
doi: 10.1111/j.1365-2125.2005.02415.x
Ahmed, R., Salmi, A., Butler, L. D., Chiller, J. M. & Oldstone, M. B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160, 521–540 (1984).
pubmed: 6332167 doi: 10.1084/jem.160.2.521
Moskophidis, D., Lechner, F., Pircher, H. & Zinkernagel, R. M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362, 758–761 (1993).
pubmed: 8469287 doi: 10.1038/362758a0
Zehn, D. & Wherry, E. J. Immune memory and exhaustion: clinically relevant lessons from the LCMV model. Adv. Exp. Med Biol. 850, 137–152 (2015).
pubmed: 26324351 doi: 10.1007/978-3-319-15774-0_10
Kretschmer, L. et al. Differential expansion of T central memory precursor and effector subsets is regulated by division speed. Nat. Commun. 11, 113 (2020).
pubmed: 31913278 pmcid: 6949285 doi: 10.1038/s41467-019-13788-w
Quéméneur, L. et al. Restriction of de novo nucleotide biosynthesis interferes with clonal expansion and differentiation into effector and memory CD8 T cells. J. Immunol. 173, 4945–4952 (2004).
pubmed: 15470036 doi: 10.4049/jimmunol.173.8.4945
Araki, K. et al. Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation. J. Exp. Med. 207, 2355–2367 (2010).
pubmed: 20921283 pmcid: 2964579 doi: 10.1084/jem.20100124
Cannarile, M. A. et al. Transcriptional regulator Id2 mediates CD8
pubmed: 17086188 doi: 10.1038/ni1403
Intlekofer, A. M. et al. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8
pubmed: 17698591 pmcid: 2118697 doi: 10.1084/jem.20070841
Kallies, A., Xin, A., Belz, G. T. & Nutt, S. L. Blimp-1 transcription factor is required for the differentiation of effector CD8
pubmed: 19664942 doi: 10.1016/j.immuni.2009.06.021
Rutishauser, R. L. et al. Transcriptional repressor Blimp-1 promotes CD8
pubmed: 19664941 pmcid: 2783637 doi: 10.1016/j.immuni.2009.05.014
Prlic, M., Hernandez-Hoyos, G. & Bevan, M. J. Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8
pubmed: 16908626 pmcid: 2118397 doi: 10.1084/jem.20060928
Sarkar, S. et al. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205, 625–640 (2008).
pubmed: 18316415 pmcid: 2275385 doi: 10.1084/jem.20071641
Snell, L. M. et al. CD8
pubmed: 30314757 pmcid: 8060917 doi: 10.1016/j.immuni.2018.08.002
Araki, K. et al. mTOR regulates memory CD8 T cell differentiation. Nature 460, 108–112 (2009).
pubmed: 19543266 pmcid: 2710807 doi: 10.1038/nature08155
Zhang, L. et al. Mammalian target of rapamycin complex 2 controls CD8 T cell memory differentiation in a Foxo1-dependent manner. Cell Rep. 14, 1206–1217 (2016).
pubmed: 26804903 doi: 10.1016/j.celrep.2015.12.095
Banerjee, A. et al. Cutting edge: the transcription factor eomesodermin enables CD8
pubmed: 20935204 doi: 10.4049/jimmunol.1002042
Cui, W., Liu, Y., Weinstein, J. S., Craft, J. & Kaech, S. M. An interleukin-21–interleukin-10–STAT3 pathway is critical for functional maturation of memory CD8
pubmed: 22118527 pmcid: 3431922 doi: 10.1016/j.immuni.2011.09.017
Teixeiro, E. et al. Different T cell receptor signals determine CD8
pubmed: 19164748 doi: 10.1126/science.1163612
Badovinac, V. P., Porter, B. B. & Harty, J. T. CD8
pubmed: 15247915 doi: 10.1038/ni1098
Bird, N. L. et al. Oseltamivir prophylaxis reduces inflammation and facilitates establishment of cross-strain protective T cell memory to influenza viruses. PLoS ONE 10, e0129768 (2015).
pubmed: 26086392 pmcid: 4473273 doi: 10.1371/journal.pone.0129768
Confavreux, C. et al. Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 13, 247–256 (2014).
pubmed: 24461574 doi: 10.1016/S1474-4422(13)70308-9
Klotz, L. et al. Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects. Sci. Transl. Med. 11, eaa05563 (2019).
doi: 10.1126/scitranslmed.aao5563
Enouz, S., Carrié, L., Merkler, D., Bevan, M. J. & Zehn, D. Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection. J. Exp. Med. 209, 1769–1779 (2012).
pubmed: 22987800 pmcid: 3457731 doi: 10.1084/jem.20120905
Baazim, H. et al. CD8
pubmed: 31110314 pmcid: 6531346 doi: 10.1038/s41590-019-0397-y
Kaech, S. M. & Cui, W. Transcriptional control of effector and memory CD8
pubmed: 23080391 pmcid: 4137483 doi: 10.1038/nri3307
Bannard, O., Kraman, M. & Fearon, D. T. Secondary replicative function of CD8
pubmed: 19164749 pmcid: 2653633 doi: 10.1126/science.1166831
Youngblood, B. et al. Effector CD8 T cells dedifferentiate into long-lived memory cells. Nature 552, 404–409 (2017).
pubmed: 29236683 pmcid: 5965677 doi: 10.1038/nature25144
Kim, S. K. et al. Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proc. Natl Acad. Sci. USA 95, 10814–10819 (1998).
pubmed: 9724787 pmcid: 27978 doi: 10.1073/pnas.95.18.10814
Battegay, M. et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33, 191–198 (1991).
pubmed: 1939506 doi: 10.1016/0166-0934(91)90018-U
Heer, A. K., Harris, N. L., Kopf, M. & Marsland, B. J. CD4
pubmed: 18981118 doi: 10.4049/jimmunol.181.10.6984
Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature 571, 265–269 (2019).
pubmed: 31207605 doi: 10.1038/s41586-019-1326-9
Koster, J. & Rahmann, S. Snakemake—a scalable bioinformatics workflow engine. Bioinformatics 34, 3600 (2018).
pubmed: 29788404 doi: 10.1093/bioinformatics/bty350
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
pubmed: 24695404 pmcid: 4103590 doi: 10.1093/bioinformatics/btu170
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Anders, S., Pyl, P. T. & Huber, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).
pubmed: 25260700 doi: 10.1093/bioinformatics/btu638
Ewels, P., Magnusson, M., Lundin, S. & Kaller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047–3048 (2016).
pubmed: 27312411 pmcid: 5039924 doi: 10.1093/bioinformatics/btw354
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792 pmcid: 4402510 doi: 10.1093/nar/gkv007
Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2016).
Kolde, R. pheatmap: Pretty Heatmaps. r package version 1.0.12 . https://CRAN.R-project.org/package=pheatmap (2019).
Waltman, L & Jan van Eck, Nees. A smart local moving algorithm for large-scale modularity-based community detection. N.J. Eur. Phys. J. B (2013).
Soumillon, M., Cacchiarelli, D., Semrau, S., Oudenaarden, A. & Mikkelsen, T. S. Characterization of directed differentiation by high-throughput single-cell RNA-seq. Preprint at bioRxiv https://doi.org/10.1101/003236 (2014).
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet Journal https://doi.org/10.14806/ej.17.1.200 (2011).
Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202–1214 (2015).
pubmed: 26000488 pmcid: 4481139 doi: 10.1016/j.cell.2015.05.002
McCarthy, D. J., Campbell, K. R., Lun, A. T. & Wills, Q. F. Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R. Bioinformatics 33, 1179–1186 (2017).
pubmed: 28088763 pmcid: 5408845 doi: 10.1093/bioinformatics/btw777
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495–502 (2015).
pubmed: 25867923 pmcid: 4430369 doi: 10.1038/nbt.3192
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
pubmed: 29608179 pmcid: 6700744 doi: 10.1038/nbt.4096
Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284–287 (2012).
pubmed: 22455463 pmcid: 3339379 doi: 10.1089/omi.2011.0118
Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene-set collection. Cell Syst. 1, 417–425 (2015).
pubmed: 26771021 pmcid: 4707969 doi: 10.1016/j.cels.2015.12.004
Amezquita, R. A. et al. Orchestrating single-cell analysis with Bioconductor. Nat. Methods 17, 137–145 (2020).
pubmed: 31792435 doi: 10.1038/s41592-019-0654-x
Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477 (2018).
pubmed: 29914354 pmcid: 6007078 doi: 10.1186/s12864-018-4772-0
Yang, X. et al. Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cell Rep. 13, 657–668 (2019).
doi: 10.1016/j.stemcr.2019.08.013
Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).
pubmed: 28091601 pmcid: 5241818 doi: 10.1038/ncomms14049
Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).
pubmed: 31870423 pmcid: 6927181 doi: 10.1186/s13059-019-1874-1
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 (2021).
pubmed: 34062119 pmcid: 8238499 doi: 10.1016/j.cell.2021.04.048
Angerer, P. et al. destiny: diffusion maps for large-scale single-cell data in R. Bioinformatics 32, 1241–1243 (2016).
pubmed: 26668002 doi: 10.1093/bioinformatics/btv715
Ge, H., Xu, K. & Ghahramani, Z. Turing: a language for flexible probabilistic inference. Proc. Mach. Learn. Res. 84, 1682–1690 (2018).

Auteurs

Stefanie Scherer (S)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.
Formerly Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland.

Susanne G Oberle (SG)

Formerly Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Sanofi Genzyme, Baar, Switzerland.

Kristiyan Kanev (K)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Ann-Katrin Gerullis (AK)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Ming Wu (M)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Gustavo P de Almeida (GP)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Daniel J Puleston (DJ)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.

Francesc Baixauli (F)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.

Lilian Aly (L)

Institute for Experimental Neuroimmunology, Technical University of Munich School of Medicine, Munich, Germany.
Department of Neurology, Technical University of Munich School of Medicine, Munich, Germany.

Alessandro Greco (A)

Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Tamar Nizharadze (T)

Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Nils B Becker (NB)

Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Madlaina V Hoesslin (MV)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Lara V Donhauser (LV)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Jacqueline Berner (J)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Talyn Chu (T)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Hayley A McNamara (HA)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Zeynep Esencan (Z)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.
Medpace Germany, Munich, Germany.

Patrick Roelli (P)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.
Spatial Transcriptomics AB, Stockholm, Sweden.

Christine Wurmser (C)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Ingo Kleiter (I)

Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke, Berg, Germany.
Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.

Maria J G T Vehreschild (MJGT)

Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.

Christoph A Mayer (CA)

Neurologische Gemeinschaftspraxis am Kaiserplatz, Frankfurt, Germany.

Percy Knolle (P)

Institute of Molecular Immunology, School of Medicine, Technical University of Munich (TUM), Munich, Germany.
German Center for Infection Research (DZIF), Munich, Germany.
Institute of Molecular Immunology, School of Life Science, Technical University of Munich (TUM), Munich, Germany.

Martin Klingenspor (M)

Chair for Molecular Nutritional Medicine, School of Life Sciences, Technical University of Munich, Freising, Germany.

Valeria Fumagalli (V)

Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.

Matteo Iannacone (M)

Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.

Martin Prlic (M)

Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Department of Global Health, University of Washington, Seattle, WA, USA.

Thomas Korn (T)

Institute for Experimental Neuroimmunology, Technical University of Munich School of Medicine, Munich, Germany.
Department of Neurology, Technical University of Munich School of Medicine, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Erika L Pearce (EL)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Bloomberg-Kimmel Institute for Cancer Immunotherapy, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

Thomas Höfer (T)

Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Anna M Schulz (AM)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany. anna.schulz@tum.de.

Dietmar Zehn (D)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany. dietmar.zehn@tum.de.
Formerly Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland. dietmar.zehn@tum.de.

Articles similaires

A key role for P2RX5 in brown adipocyte differentiation and energy homeostasis.

Maria Razzoli, Seth McGonigle, Bhavani Shankar Sahu et al.
1.00
Animals Adipocytes, Brown Mice Cell Differentiation Male
Tumor Microenvironment Nanoparticles Immunotherapy Cellular Senescence Animals
Testicular Neoplasms Neoplasms, Germ Cell and Embryonal Humans Cisplatin Jumonji Domain-Containing Histone Demethylases

Identification of CD141

Gabee Park, Dae Yeon Hwang, Do Young Kim et al.
1.00
Humans Mesenchymal Stem Cells Animals Mice Mesenchymal Stem Cell Transplantation

Classifications MeSH